Kyverna Therapeutics Inc (KYTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,496 | -26,693 | -60,366 | -39,699 | -24,234 |
| Depreciation Amortization | 1,012 | 482 | 1,707 | 1,245 | 807 |
| Accounts payable and accrued liabilities | 967 | 3,068 | 4,083 | 1,104 | 595 |
| Other Working Capital | 2,570 | -1,838 | 3,424 | 2,415 | -955 |
| Other Operating Activity | 1,247 | -544 | -1,258 | 1,088 | 1,072 |
| Operating Cash Flow | $-49,700 | $-25,525 | $-52,410 | $-33,847 | $-22,715 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -189,229 | -122,336 | -8,164 | -40,179 | 13,683 |
| PPE Investments | -1,571 | -543 | -621 | -287 | -31 |
| Investing Cash Flow | $-190,800 | $-122,879 | $-8,785 | $-40,466 | $13,652 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 59,900 | 59,900 | 25,059 |
| Debt Repayment | -467 | -231 | -781 | -562 | -357 |
| Common Stock Issued | 341,308 | 341,235 | 645 | 370 | 60 |
| Other Financing Activity | -3,361 | -2,955 | -1,646 | -156 | 0 |
| Financing Cash Flow | $337,480 | $338,049 | $58,118 | $59,552 | $24,762 |
| Beginning Cash Position | 35,212 | 35,212 | 38,289 | 38,289 | 38,289 |
| End Cash Position | 132,192 | 224,857 | 35,212 | 23,528 | 53,988 |
| Net Cash Flow | $96,980 | $189,645 | $-3,077 | $-14,761 | $15,699 |
| Free Cash Flow | |||||
| Operating Cash Flow | -49,700 | -25,525 | -52,410 | -33,847 | -22,715 |
| Capital Expenditure | -1,571 | -543 | -621 | -287 | -31 |
| Free Cash Flow | -51,271 | -26,068 | -53,031 | -34,134 | -22,746 |